pharmaceutical investing Aerpio Pharmaceuticals Announces Uplisting to Nasdaq Capital Market and Pricing of $45.0 Million Public Offering of Common Stock
Homerun Resources Inc. Files for Approval of $3 Million Financing; Updates $6 Million Institutional Financing
